Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hyperphagia × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8 Other hematologic neoplasm 2 Other 1 Genitourinary 1

Conditions

Obesity 192 Neoplasms 73 Breast Neoplasms 61 Mucositis 59 Sexual Dysfunction, Physiological 55 Overweight 50 Polycystic Ovary Syndrome 48 Dyspnea 29 Motor Activity 27 Constipation 27 Head and Neck Neoplasms 26 Prostatic Neoplasms 23 Weight Loss 22 Multiple Endocrine Neoplasia Type 1 17 Colorectal Neoplasms 17 Stomatitis 15 Pain 14 Opioid-Induced Constipation 14 Lung Neoplasms 14 Depression 13 Diabetes Mellitus 12 Insulin Resistance 11 Endometrial Neoplasms 11 Cardiovascular Diseases 11 Sexuality 10 Sexual Dysfunctions, Psychological 10 Fatigue 9 Diabetes Mellitus, Type 2 9 Stomach Neoplasms 8 Sedentary Behavior 8

Interventions

fish oil triglycerides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00533078 2015-07-23

LUNCH1

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡